Phase II Study of Carboplatin+nab-Paclitaxel for Non-small Cell Lung Cancer with Interstitial Pneumonitis Study of evaluating SPARC expressio
Not Applicable
- Conditions
- Advanced non-small cell carcinoma with interstitial pneumoniae
- Registration Number
- JPRN-UMIN000016071
- Lead Sponsor
- Yushima Lung Cancer Oncology Group (YLOG)
- Brief Summary
recruiting
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The cases excepting the above.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method